The financial and commercial landscape of the Biopharmaceuticals Market is facing intensifying pressure from both regulatory bodies demanding price reductions and the upcoming wave of patent expirations that threaten significant revenue streams for originator drugs, and this dual challenge is compelling large biopharma companies to implement aggressive portfolio optimization and strategic...